tetrabenazine has been researched along with Nervous System Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, SC; Spigarelli, MG | 1 |
| Bentivoglio, AR; Fasano, A | 1 |
| Griggs, RC; Murphy, SM; Puwanant, A | 1 |
| Del Zompo, M; Gessa, GL; Piccardi, MP; Quartu, M; Ruiu, S; Vaccari, A | 1 |
| Jankovic, J; Orman, J | 1 |
3 review(s) available for tetrabenazine and Nervous System Disorders
| Article | Year |
|---|---|
Pharmacology and pharmacogenomics of neurological medications used in pregnancy.
Topics: Anticonvulsants; Codeine; Dextromethorphan; Female; Humans; Nervous System Diseases; Pharmacogenetics; Pregnancy; Pregnancy Complications; Teratogens; Tetrabenazine | 2013 |
Tetrabenazine.
Topics: Adrenergic Uptake Inhibitors; Animals; Drug Interactions; Humans; Models, Animal; Nervous System Diseases; Randomized Controlled Trials as Topic; Tetrabenazine | 2009 |
Unintended effects of orphan product designation for rare neurological diseases.
Topics: Adrenocorticotropic Hormone; alpha-Glucosidases; Anti-Dyskinesia Agents; Biological Products; Child; Drug Approval; Health Care Sector; Humans; Infant; Nervous System Diseases; Orphan Drug Production; Pharmaceutical Preparations; Spasms, Infantile; Tetrabenazine; United States | 2012 |
1 trial(s) available for tetrabenazine and Nervous System Disorders
| Article | Year |
|---|---|
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
Topics: Chorea; Clinical Trials as Topic; Drug Synergism; Dystonia; Humans; Lithium; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease, Secondary; Tetrabenazine; Tic Disorders | 1988 |
1 other study(ies) available for tetrabenazine and Nervous System Disorders
| Article | Year |
|---|---|
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Biomarkers; Brain; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Mice; Microscopy, Electron; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Synaptic Vesicles; Tetrabenazine | 1993 |